Literature DB >> 24189005

Concomitant unruptured intracranial aneurysms and carotid artery stenosis: an institutional review of patients undergoing carotid revascularization.

Matthew J Borkon1, Han Hoang1, Caron Rockman1, Firas Mussa1, Neal S Cayne1, Thomas Riles1, Jafar J Jafar2, Frank J Veith1, Mark A Adelman1, Thomas S Maldonado3.   

Abstract

BACKGROUND: The incidence of concomitant carotid artery stenosis and unruptured intracranial aneurysms (UIAs) has been reported at between 0.5% and 5%. In these patients, treatment strategies must balance the risk of ischemic stroke with the risk of aneurysmal rupture. Several studies have addressed the natural course of UIAs in the setting of carotid revascularization; however, the final recommendations are not uniform. The purpose of this study was to review our institutional experience with concomitant UIAs and carotid artery stenosis.
METHODS: We performed a retrospective review of all patients with carotid artery stenosis who underwent carotid artery endarterectomy (CEA) or carotid artery stenting (CAS) at our institution between 2003 and 2010. Only patients with preoperative imaging demonstrating intracranial circulation were included. Charts were reviewed for patients' demographic and clinical data, duration of follow-up, and aneurysm size and location. Patients were stratified into 2 groups: carotid artery stenosis with unruptured intracranial aneurysm (CS/UIA) and carotid artery stenosis without intracranial aneurysm (CS).
RESULTS: Three hundred five patients met the inclusion criteria and had a total of 316 carotid procedures (CAS or CEA) performed. Eleven patients were found to have UIAs (3.61%) prior to carotid revascularization. Male and female prevalence was 2.59% and 5.26% (P = 0.22), respectively. Patients' demographics did not differ significantly between the 2 groups. The average aneurysm size was 3.25 ± 2.13 mm, and the most common location was the cavernous segment of the internal carotid artery. No patient in the study had aneurysm rupture, and the mean follow-up time was 26.5 months for the CS/UIA group.
CONCLUSIONS: Concomitant carotid artery stenosis and UIAs is a rare entity. Carotid revascularization does not appear to increase the risk of rupture for small aneurysms (<10 mm) in the midterm. Although not statistically significant, there was a higher incidence of aneurysms found in females in our patient population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24189005     DOI: 10.1016/j.avsg.2013.06.013

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

1.  Single-stage endovascular treatment in patients with severe extracranial large vessel stenosis and concomitant ipsilateral unruptured intracranial aneurysm.

Authors:  Emre Kaçar; Ömer Fatih Nas; Cüneyt Erdoğan; Bahattin Hakyemez
Journal:  Diagn Interv Radiol       Date:  2015 Nov-Dec       Impact factor: 2.630

2.  Surgical treatment and perioperative management of intracranial aneurysms in Chinese patients with ischemic cerebrovascular diseases: a case series.

Authors:  Yangrui Zheng; Chen Wu
Journal:  BMC Neurol       Date:  2018-09-14       Impact factor: 2.474

3.  Surgery for Triple Pathology of Giant Vestibular Schwannoma Associated with Carotid Artery Stenosis and Intracranial Aneurysm: Case Report.

Authors:  Andriy Sirko; Lyudmila Dzyak; Dmytro Romanukha; Grigoriy Pilipenko; Yuri Cherednychenko
Journal:  J Neurol Surg Rep       Date:  2018-06-28

4.  Intervals of endovascular treatment for coincidental non-adjacent unruptured aneurysms in patients with symptomatic intracranial atherosclerotic stenosis.

Authors:  Hengwei Jin; Jing Wang; Xiangyu Meng; Youxiang Li; Hongwei He
Journal:  Front Neurol       Date:  2022-09-23       Impact factor: 4.086

5.  Simultaneous internal carotid artery stenosis and ipsilateral anterior communicating artery saccular aneurysm treatment: a case report.

Authors:  Alexander V Korotkikh; Dmitriy A Nekrasov; Anton A Khilchuk; Sergey G Scherbak; Andrey M Sarana
Journal:  Radiol Case Rep       Date:  2020-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.